Aminocaproic Acid Injection and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Aminocaproic Acid Injection and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aminocaproic acid
Brand name: Amicar
Synonyms: Aminocaproic acid, Aminocaproic Acid
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aminocaproic Acid Injection-Insulin glargine, recombinant Subcutaneous
- Aminocaproic Acid Injection-Insulin glulisine
- Aminocaproic Acid Injection-Insulin Glulisine (Cartridges and Pens)
- Aminocaproic Acid Injection-Insulin Glulisine (Vials)
- Aminocaproic Acid Injection-Insulin glulisine Subcutaneous
- Aminocaproic Acid Injection-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Aminocaproic Acid Injection Solution
- Insulin glargine and lixisenatide Subcutaneous-Aminocaproic acid Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Aminocaproic Acid Oral Liquid
- Insulin glargine and lixisenatide Subcutaneous-Aminocaproic Acid Oral Solution
- Insulin glargine and lixisenatide Subcutaneous-Aminocaproic Acid Tablets
- Insulin glargine and lixisenatide Subcutaneous-Aminofen